Physician profile
Min Y Cha
NPI 1700972403
$3,917.24
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,131 · 2020: $489 · 2021: $736 · 2022: $318 · 2023: $221 · 2024: $22.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $243.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $1,078.21 | 2019-2023 | |
| Amgen INC. | $584.34 | 2019-2024 | Prolia, Evenity |
| Abbvie INC. | $402.60 | 2019-2023 | Viberzi, Linzess |
| Merz North America, INC. | $312.17 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $288.35 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $271.83 | 2019 | |
| Glaxosmithkline, LLC. | $159.06 | 2019-2023 | Trelegy Ellipta |
| Novo Nordisk INC | $144.79 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2021 | |
| Lilly USA, LLC | $89.08 | 2019-2023 | Jardiance, Emgality |
| Radius Health, INC. | $77.34 | 2019 | |
| Allergan, INC. | $65.75 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $57.64 | 2019-2020 | |
| Gilead Sciences, INC. | $51.09 | 2019 | |
| Galderma Laboratories, L.P. | $38.50 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $34.48 | 2019 | |
| Boston Scientific Corporation | $31.11 | 2020 | |
| Eisai INC. | $24.81 | 2021 | |
| Nestle Healthcare Nutrition INC. | $23.25 | 2023 | |
| Janssen Pharmaceuticals, INC | $21.28 | 2019 | |
| Astellas Pharma US INC | $18.64 | 2019 | |
| Merck Sharp & Dohme LLC | $17.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Min Cha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.